-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Immune Reconstitution Following Stem Cell Transplantation

Program: Education Program
Session: Immunological Ctrl-Alt-Del: Stem Cell Transplantation for Hematological Malignancies
Saturday, December 5, 2015, 9:30 AM-11:00 AM
Tangerine 1 (WF1), Level 2 (Orange County Convention Center)
Sunday, December 6, 2015, 9:30 AM-11:00 AM
Tangerine 3 (WF3-4), Level 2 (Orange County Convention Center)

Marcel van den Brink, MD, PhD

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Disclosures: van den Brink: Novartis: Consultancy , Membership on an entity’s Board of Directors or advisory committees ; Boehringer Ingelheim: Consultancy , Other: Advisory board attendee ; Regeneron: Honoraria ; Merck: Honoraria ; Tobira Therapeutics: Other: Advisory board attendee .

See more of: Immunological Ctrl-Alt-Del: Stem Cell Transplantation for Hematological Malignancies
See more of: Education Program
<< Previous Presentation | Next Presentation >>